Abstract:Rock inhibitor (RI) at the widely used 10 μM induces early gastrulation-like differentiation of human iPSCs (hiPSCs) in 3D.Reducing RI to 1 μM retains the high pluripotency of hiPSCs in inner cell mass-like solid spheroids in 3D.Reducing RI to 1 μM shortens the time needed for 3D cardiac differentiation of hiPSCs by ~1 week.Reducing RI to 1 μM doubles the percentage of beating cardiac spheroids after 3D cardiac differentiation of hiPSCs.Cardiomyocytes differentiated from human induced pluripotent stem cells (iPSCs) are valuable for the understanding/treatment of the deadly heart diseases and their drug screening. However, the very much needed homogeneous 3D cardiac differentiation of human iPSCs is still challenging. Here, it is discovered surprisingly that Rock inhibitor (RI), used ubiquitously to improve the survival/yield of human iPSCs, induces early gastrulation-like change to human iPSCs in 3D culture and may cause their heterogeneous differentiation into all the three germ layers (i.e., ectoderm, mesoderm, and endoderm) at the commonly used concentration (10 μM). This greatly compromises the capacity of human iPSCs for homogeneous 3D cardiac differentiation. By reducing the RI to 1 μM for 3D culture, the human iPSCs retain high pluripotency/quality in inner cell mass-like solid 3D spheroids. Consequently, the beating efficiency of 3D cardiac differentiation can be improved to more than 95 % in ~7 days (compared to less than ~50 % in 14 days for the 10 μM RI condition). Furthermore, the outset beating time (OBT) of all resultant cardiac spheroids (CSs) is synchronized within only 1 day and they form a synchronously beating 3D construct after 5-day culture in gelatin methacrylol (GelMA) hydrogel, showing high homogeneity (in terms of the OBT) in functional maturity of the CSs. Moreover, the resultant cardiomyocytes are of high quality with key functional ultrastructures and highly responsive to cardiac drugs. These discoveries may greatly facilitate the utilization of human iPSCs for understanding and treating heart diseases.Rock inhibitor (RI) at 10 μM induces early gastrulation-like heterogeneous differentiation of human iPSCs and compromises their cardiac differentiation in 3D. Importantly, reducing RI to 1 μM retains human iPSCs in solid inner cell mass-like spheroids with high pluripotency for efficient and homogeneous cardiac differentiation in 3D. This discovery may greatly facilitate human iPSCs-based therapy and modeling of heart diseases.Download : Download high-res image (399KB)Download : Download full-size image

The Efficiency of In Vitro Differentiation of Primate iPSCs into Cardiomyocytes Depending on Their Cell Seeding Density and Cell Line Specificity

Inducing Pluripotency for Disease Modeling, Drug Development and Craniofacial Applications.

Differentiation and Characterization of Rhesus Monkey Atrial and Ventricular Cardiomyocytes from Induced Pluripotent Stem Cells.

Effect of human donor cell source on differentiation and function of cardiac induced pluripotent stem cells.

Human-Induced Pluripotent Stem Cell-Based Differentiation of Cardiomyocyte Subtypes for Drug Discovery and Cell Therapy

Human Induced Pluripotent Stem Cell for Modeling Cardiovascular Diseases.

Cardiac differentiation of chimpanzee induced pluripotent stem cell lines with different subspecies backgrounds

Genetic heterogeneity of induced pluripotent stem cells: results from 24 clones derived from a single C57BL/6 mouse

Comparative analysis of the cardiomyocyte differentiation potential of induced pluripotent stem cells reprogrammed from human atrial or ventricular fibroblasts

Neural Differentiation of Human Induced Pluripotent Stem Cells Follows Developmental Principles but with Variable Potency

Improving the Reprogramming Efficiency of Somatic Cells to Induced Pluripotent Stem Cells.

Generation and Expansion of Human Cardiomyocytes from Patient Peripheral Blood Mononuclear Cells

Efficient and reproducible generation of human iPSC-derived cardiomyocytes using a stirred bioreactor

Overcoming barriers to the clinical utilization of iPSCs: reprogramming efficiency, safety and quality

Stem cell‐derived cardiomyocyte heterogeneity confounds electrophysiological insights

Techniques for the induction of human pluripotent stem cell differentiation towards cardiomyocytes

Rock inhibitor may compromise human induced pluripotent stem cells for cardiac differentiation in 3D

Increased Neuronal Differentiation Efficiency in High Cell Density-Derived Induced Pluripotent Stem Cells

Comparison of cardiomycyte differentiation potential between type 1 diabetic donor- and non-diabetic donor-derived induced pluripotent stem cells.

Transcriptomic and Epigenomic Resemblance of Terminally Differentiated Cells Derived from Isogenic Human Ipscs and Nuclear Transfer Derived Escs

Methods for the derivation and use of cardiomyocytes from human pluripotent stem cells